Guangdong Jiaying Pharmaceutical Co., Ltd (SHE:002198)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Industry	382.92M	375.41M	533.23M	659.03M	574.60M
Pharmaceutical Industry Growth	2.00%	-29.60%	-19.09%	14.69%	5.80%
Unallocated Other	835.61K	760.11K	-	166.57K	112.37K
Unallocated Other Growth	9.93%	-	-	48.23%	-93.15%
Total	383.75M	376.17M	533.23M	659.20M	574.71M
Total Growth	2.02%	-29.46%	-19.11%	14.70%	5.50%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	383.16M	376.17M	533.23M	659.20M	574.71M
China Growth	1.86%	-29.46%	-19.11%	14.70%	5.50%
Overseas	588.18K	-	-	-	-
Total	383.75M	376.17M	533.23M	659.20M	574.71M
Total Growth	2.02%	-29.46%	-19.11%	14.70%	5.50%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 21, 2026

Data Sources Report a data error